Search

for
Search:

Sort by

Research

30-60 / 1000+ results

research A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen

7 citations, January 2021 in “The Journal of Sexual Medicine”

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

research Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

4 citations, March 2016 in “Dermatologic Surgery”

PRP treatment increased hair density, especially in men and younger patients with AGA.

research The Effect of Latanoprost 0.005% Solution in the Management of Scalp Alopecia Areata: A Randomized Double-Blind Placebo-Controlled Trial

2 citations, March 2022 in “Dermatologic Therapy”

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

research A Double Blind Randomized Placebo Controlled Clinical Trial of Finasteride in the Treatment of Androgenetic Alopecia

2 citations, January 2002 in “The Chinese Journal of Clinical Pharmacology”

Finasteride effectively improves hair growth in men with minimal side effects.

research Blinding in Placebo-Controlled Trials

1 citations, June 2001 in “Annals of Internal Medicine”

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Double-Blind Randomized Placebo-Controlled Study of the Efficacy and Safety of Hair Loss Prevention Shampoo Containing Salicylic Acid, Panthenol, and Niacinamide in Alopecia Patients

research Double-Blind Randomized Placebo-Controlled Study of the Efficacy and Safety of Hair Loss Prevention Shampoo Containing Salicylic Acid, Panthenol, and Niacinamide in Alopecia Patients

1 citations, April 2022 in “Toxicology and Environmental Health Sciences”

The shampoo with salicylic acid, panthenol, and niacinamide is effective and safe for preventing hair loss in people with alopecia.

research The Randomized Double-Blind Placebo-Controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

1 citations, March 2012 in “Journal of the American Academy of Dermatology”

Botulinum toxin A injections may help treat difficult cases of total hair loss.

$Treatment of Refractory Hematospermia With Finasteride: A Prospective Placebo-Controlled Study$

research Treatment of Refractory Hematospermia With Finasteride: A Prospective Placebo-Controlled Study

October 2023 in “Bangladesh journal of urology”

Finasteride effectively treats hematospermia in 3 months without side effects.

research Blinding in Placebo-Controlled Trials

June 2001 in “Annals of Internal Medicine”

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

A Randomized Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Effect of an Annurca Apple Supplement Formula in Androgenic Alopecia

research A Randomized Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Effect of an Annurca Apple Supplement Formula in Androgenic Alopecia

May 2023 in “Journal of Applied Cosmetology”

The Annurca apple supplement significantly improved hair growth in people with hair loss.

research Multicenter Double Blind Randomized Placebo Controlled Clinical Trial of Minoxidil Gel in the Treatment of Alopecia Areata

January 2006 in “The Chinese Journal of Clinical Pharmacology”

research Microneedling Plus Topical Dutasteride Solution for Androgenetic Alopecia: A Randomized Placebo-Controlled Study

June 2022 in “Journal of The European Academy of Dermatology and Venereology”

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

A Prospective Double-Blind Placebo-Controlled Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

research A Prospective Double-Blind Placebo-Controlled Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

January 2017

Platelet-rich plasma treatment significantly improved hair density and regrowth in both men and women suffering from pattern hair loss, with even better results when combined with certain medications.

research Pooled Safety and Tolerability Data from Four Placebo-Controlled Teriflunomide Studies and Extensions

72 citations, November 2015 in “Multiple Sclerosis and Related Disorders”

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

research Effects of Finasteride in Patients with Inflammatory Chronic Pelvic Pain Syndrome: A Double-Blind, Placebo-Controlled, Pilot Study

65 citations, March 1999 in “Urology”

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

research Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing Its Impact on T Regulatory Cell and NK Cell Populations

22 citations, September 2020 in “The journal of investigative dermatology/Journal of investigative dermatology”

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

$Finasteride for Treatment of Refractory Hemospermia: Prospective Placebo-Controlled Study$

research Finasteride for Treatment of Refractory Hemospermia: Prospective Placebo-Controlled Study

13 citations, April 2012 in “International Urology and Nephrology”

Sublingual Minoxidil for the Treatment of Male and Female Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase 1B Clinical Trial

research Sublingual Minoxidil for the Treatment of Male and Female Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase 1B Clinical Trial

5 citations, August 2021 in “Journal of The European Academy of Dermatology and Venereology”

Sublingual minoxidil safely promotes hair growth.

Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women

research Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women

3 citations, May 2018 in “Reproductive Sciences”

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Efficacy and Tolerability of HDMHG0401-10 in Patients with Androgenetic Alopecia: A Randomized Double-Blind Placebo-Controlled Trial

research Efficacy and Tolerability of HDMHG0401-10 in Patients with Androgenetic Alopecia: A Randomized Double-Blind Placebo-Controlled Trial

1 citations, December 2005 in “임상약리학회지”

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

A Randomized, Double-Blind, Placebo-Controlled, Half-Head Study to Evaluate the Effects of Platelet-Rich Plasma on Androgenetic Alopecia

research A Randomized, Double-Blind, Placebo-Controlled, Half-Head Study to Evaluate the Effects of Platelet-Rich Plasma on Androgenetic Alopecia

May 2024 in “Cosmoderma”

PRP injections did not significantly improve hair growth in men with androgenetic alopecia.

research Review of the Literature: A Placebo-Controlled Split Scalp Study of PRP for Male Pattern Baldness

November 2015 in “Hair transplant forum international”

PRP may help with hair regrowth in male pattern baldness, but more research is needed.

research Faculty Opinions Recommendation of Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

May 2016 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

research Efficacy and Tolerability of HDMHG0401-10 in Patients with Androgenetic Alopecia: A Randomized Double-Blind Placebo-Controlled Trial

January 2005 in “Translational and Clinical Pharmacology”

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double-Blind, Placebo-Controlled Trial

research Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double-Blind, Placebo-Controlled Trial

94 citations, January 2000 in “The Journal of Clinical Endocrinology and Metabolism”

Spironolactone most effective for hirsutism, but has side effects.

research Efficacy of an Oral Contraceptive Containing EE 0.03 mg and CMA 2 mg (Belara) in Moderate Acne Resolution: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial

42 citations, May 2009 in “Contraception”

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

Curcuma Aeruginosa, A Novel Botanically Derived 5α-Reductase Inhibitor In The Treatment Of Male-Pattern Baldness: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

research Curcuma Aeruginosa, A Novel Botanically Derived 5α-Reductase Inhibitor In The Treatment Of Male-Pattern Baldness: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

34 citations, July 2011 in “Journal of Dermatological Treatment”

Curcuma aeruginosa extract combined with minoxidil effectively treats male-pattern baldness.

A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of a Marine Complex Supplement to Promote Hair Growth in Men with Thinning Hair

research A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of a Marine Complex Supplement to Promote Hair Growth in Men with Thinning Hair

25 citations, August 2016 in “Journal of Cosmetic Dermatology”

The marine complex supplement significantly improved hair growth in men with thinning hair without adverse effects.

A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair

research A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair

22 citations, January 2015 in “Dermatology Research and Practice”

An extra-strength marine protein supplement helped increase hair growth and decrease hair shedding in women with thinning hair.

A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men

research A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men

19 citations, January 2015 in “Skin Pharmacology and Physiology”

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

← Previous page Next page →